自己免疫性肝疾患患者への新型コロナウイルスワクチン接種に関する情報提供による心理的影響

背景:Coronavirus disease 2019(COVID-19)に対し開発されたワクチンの有効性が報告されたが,併存症を有する症例への効果等の情報は限定的である.目的:COVID-19関連の情報提供が自己免疫性肝疾患患者のワクチン接種意識に及ぼす影響を検討した.対象・方法:自己免疫性肝疾患患者連続40症例を対象に「難治性の肝・胆道疾患に関する調査研究」班からのCOVID-19関連の公開文章がワクチン接種意識に及ぼす変化を評価した.結果:原発性胆汁性胆管炎15名,自己免疫性肝炎18名,その他7名であった.慢性肝炎34名,年齢中央値は62歳,女性33名であった.情報提供前後でワクチンを「...

Full description

Saved in:
Bibliographic Details
Published in肝臓 Vol. 62; no. 10; pp. 613 - 619
Main Authors 滝川, 康裕, 柿坂, 啓介, 吉田, 雄一, 鈴木, 悠地
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本肝臓学会 01.10.2021
Subjects
Online AccessGet full text
ISSN0451-4203
1881-3593
DOI10.2957/kanzo.62.613

Cover

Abstract 背景:Coronavirus disease 2019(COVID-19)に対し開発されたワクチンの有効性が報告されたが,併存症を有する症例への効果等の情報は限定的である.目的:COVID-19関連の情報提供が自己免疫性肝疾患患者のワクチン接種意識に及ぼす影響を検討した.対象・方法:自己免疫性肝疾患患者連続40症例を対象に「難治性の肝・胆道疾患に関する調査研究」班からのCOVID-19関連の公開文章がワクチン接種意識に及ぼす変化を評価した.結果:原発性胆汁性胆管炎15名,自己免疫性肝炎18名,その他7名であった.慢性肝炎34名,年齢中央値は62歳,女性33名であった.情報提供前後でワクチンを「接種する」は23名から34名,「(とても)不安」は29名から14名になった.結語:自己免疫性肝疾患患者のワクチン接種の自己決定を情報提供により援助できた.また,ワクチン接種に対する不安も軽減できた.
AbstractList 背景:Coronavirus disease 2019(COVID-19)に対し開発されたワクチンの有効性が報告されたが,併存症を有する症例への効果等の情報は限定的である.目的:COVID-19関連の情報提供が自己免疫性肝疾患患者のワクチン接種意識に及ぼす影響を検討した.対象・方法:自己免疫性肝疾患患者連続40症例を対象に「難治性の肝・胆道疾患に関する調査研究」班からのCOVID-19関連の公開文章がワクチン接種意識に及ぼす変化を評価した.結果:原発性胆汁性胆管炎15名,自己免疫性肝炎18名,その他7名であった.慢性肝炎34名,年齢中央値は62歳,女性33名であった.情報提供前後でワクチンを「接種する」は23名から34名,「(とても)不安」は29名から14名になった.結語:自己免疫性肝疾患患者のワクチン接種の自己決定を情報提供により援助できた.また,ワクチン接種に対する不安も軽減できた.
Author 滝川, 康裕
柿坂, 啓介
吉田, 雄一
鈴木, 悠地
Author_xml – sequence: 1
  fullname: 滝川, 康裕
  organization: 岩手医科大学内科学講座消化器内科肝臓分野
– sequence: 1
  fullname: 柿坂, 啓介
  organization: 岩手医科大学内科学講座消化器内科肝臓分野
– sequence: 1
  fullname: 吉田, 雄一
  organization: 岩手医科大学内科学講座消化器内科肝臓分野
– sequence: 1
  fullname: 鈴木, 悠地
  organization: 岩手医科大学内科学講座消化器内科肝臓分野
BookMark eNo9kElLw0AcxQdRsGpvfo3UWZJM5qaIGxS86DlM0kRbtUrrRU9mYlUUtaeCigvuWFyKB_Wgfpi_Seq3sC4Ij_fg9-AdXhdqL84XPYR6Cc5QYfC-GVlcns-YNGMS1oZSxLKIxgzB2lEK6wbRdIpZJ0qXy3kHY2pyLARNoaC5fhM9NaLKdlKrxytXTXWY1N5iddZSc6UCwTMEd3HtITraAvUI4S2Em6AuQZ1DWAf1AuE9qHsIAwgf452L5PoOgvpn7RSCPVBbcViJThrxbvXj7aDFQW20YPQeJtW1ZH81em18Hr_3oA5fzpa99F92o8nhoYnBUS07PjI2OJDVCpQzohmU54j0nRwxHJe5wmQm96lFXUqcnKXniG65jHuCceFj4RrUF5gLnXJXSMN0GOtG_b-7hfKinPLshVJ-TpaWbFlazLuznv3zn21Sm-Bvb734X7nTsmQXJPsCXxCaaw
ContentType Journal Article
Copyright 2021 一般社団法人 日本肝臓学会
Copyright_xml – notice: 2021 一般社団法人 日本肝臓学会
DOI 10.2957/kanzo.62.613
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1881-3593
EndPage 619
ExternalDocumentID article_kanzo_62_10_62_613_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
CS3
JSF
KQ8
OK1
P2P
RJT
ID FETCH-LOGICAL-j2731-527d1afbd15bc3c96367f282c21bd84d148c37e9379f09c52f9079427c9a56b33
ISSN 0451-4203
IngestDate Wed Sep 03 06:31:10 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2731-527d1afbd15bc3c96367f282c21bd84d148c37e9379f09c52f9079427c9a56b33
OpenAccessLink https://www.jstage.jst.go.jp/article/kanzo/62/10/62_613/_article/-char/ja
PageCount 7
ParticipantIDs jstage_primary_article_kanzo_62_10_62_613_article_char_ja
PublicationCentury 2000
PublicationDate 20211000
PublicationDateYYYYMMDD 2021-10-01
PublicationDate_xml – month: 10
  year: 2021
  text: 20211000
PublicationDecade 2020
PublicationTitle 肝臓
PublicationTitleAlternate 肝臓
PublicationYear 2021
Publisher 一般社団法人 日本肝臓学会
Publisher_xml – name: 一般社団法人 日本肝臓学会
References 11) Kakisaka K, Sakai A, Yoshida Y, et al. Hepatitis B Surface Antibody Titers at One and Two Years after Hepatitis B Virus Vaccination in Healthy Young Japanese Adults. Intern Med 2019; 58: 2349-2355
8) Dowdle WR. The principles of disease elimination and eradication. Bull World Health Organ 1998; 76 (Suppl 2): 22-25
1) Baden LR, El Sahly HM, Essink B, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med 2021; 384: 403-416
9) Aylward B, Hennessey KA, Zagaria N, et al. When is a disease eradicable? 100 years of lessons learned. Am J Public Health 2000; 90: 1515-1520
3) Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 2021; 397: 99-111
10) Castells MC, Phillips EJ. Maintaining Safety with SARS-CoV-2 Vaccines. N Engl J Med 2021; 384: 643-649
13) Rottem M, Shoenfeld Y. Vaccination and allergy. Curr Opin Otolaryngol Head Neck Surg 2004; 12: 223-231
4) Freeman D, Loe BS, Chadwick A, et al. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychol Med 2020; 1-15
2) Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med 2020; 383: 2603-2615
14) Sakai A, Noguchi E, Fukushima T, et al. Identification of amino acids in antigen-binding site of class II HLA proteins independently associated with hepatitis B vaccine response. Vaccine 2017; 35: 703-710
15) Schwartz KL, Neale AV, Northrup J, et al. Racial similarities in response to standardized offer of influenza vaccination. A MetroNet study. J Gen Intern Med 2006; 21: 346-351
12) Nishida N, Sugiyama M, Ohashi J, et al. Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines. Sci Rep 2021; 11: 3703
5) Wouters OJ, Shadlen KC, Salcher-Konrad M, et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet 2021; 397: 1023-1034
7) Elkins G, Staniunas R, Rajab MH, et al. Use of a numeric visual analog anxiety scale among patients undergoing colorectal surgery. Clin Nurs Res 2004; 13: 237-244
6) Tan SS, Goonawardene N. Internet Health Information Seeking and the Patient-Physician Relationship: A Systematic Review. J Med Internet Res 2017; 19: e9
References_xml – reference: 11) Kakisaka K, Sakai A, Yoshida Y, et al. Hepatitis B Surface Antibody Titers at One and Two Years after Hepatitis B Virus Vaccination in Healthy Young Japanese Adults. Intern Med 2019; 58: 2349-2355
– reference: 5) Wouters OJ, Shadlen KC, Salcher-Konrad M, et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet 2021; 397: 1023-1034
– reference: 14) Sakai A, Noguchi E, Fukushima T, et al. Identification of amino acids in antigen-binding site of class II HLA proteins independently associated with hepatitis B vaccine response. Vaccine 2017; 35: 703-710
– reference: 15) Schwartz KL, Neale AV, Northrup J, et al. Racial similarities in response to standardized offer of influenza vaccination. A MetroNet study. J Gen Intern Med 2006; 21: 346-351
– reference: 12) Nishida N, Sugiyama M, Ohashi J, et al. Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines. Sci Rep 2021; 11: 3703
– reference: 13) Rottem M, Shoenfeld Y. Vaccination and allergy. Curr Opin Otolaryngol Head Neck Surg 2004; 12: 223-231
– reference: 1) Baden LR, El Sahly HM, Essink B, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med 2021; 384: 403-416
– reference: 9) Aylward B, Hennessey KA, Zagaria N, et al. When is a disease eradicable? 100 years of lessons learned. Am J Public Health 2000; 90: 1515-1520
– reference: 10) Castells MC, Phillips EJ. Maintaining Safety with SARS-CoV-2 Vaccines. N Engl J Med 2021; 384: 643-649
– reference: 7) Elkins G, Staniunas R, Rajab MH, et al. Use of a numeric visual analog anxiety scale among patients undergoing colorectal surgery. Clin Nurs Res 2004; 13: 237-244
– reference: 8) Dowdle WR. The principles of disease elimination and eradication. Bull World Health Organ 1998; 76 (Suppl 2): 22-25
– reference: 2) Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med 2020; 383: 2603-2615
– reference: 6) Tan SS, Goonawardene N. Internet Health Information Seeking and the Patient-Physician Relationship: A Systematic Review. J Med Internet Res 2017; 19: e9
– reference: 3) Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 2021; 397: 99-111
– reference: 4) Freeman D, Loe BS, Chadwick A, et al. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychol Med 2020; 1-15
SSID ssib002670992
ssib000940394
ssib002670224
ssib058493441
ssj0069113
ssib005879686
ssib002484534
Score 2.2786596
Snippet 背景:Coronavirus disease...
SourceID jstage
SourceType Publisher
StartPage 613
SubjectTerms COVID-19
information sharing
vaccination
ワクチン
情報共有
Title 自己免疫性肝疾患患者への新型コロナウイルスワクチン接種に関する情報提供による心理的影響
URI https://www.jstage.jst.go.jp/article/kanzo/62/10/62_613/_article/-char/ja
Volume 62
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 肝臓, 2021/10/01, Vol.62(10), pp.613-619
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR3LbtQwMEJFQlwQT_FWD_i4JbETxz4mu1lVoCIhtRK3VZLdPRSpIFQunLrZFhAV0NNKgHiIt6h4VByAA-3HmN1t_4LxONmGx4GHZEUTe2Y8DzuesZzEsk4x4SVumrQqzaYHCQqPmxWRxhDIJT6LISMS7Vjvd0yd45Mz7pkL3oUdY4ulU0tX55OJ9Npv3yv5F69CHfhVvyX7F54dMYUKgMG_cAUPw_WPfEwiQSCZDwISeST0SehoQECpkcgnkpMgJBHXpxkCH5EpkUVTGGETJQErAUIjA4eIQYxJQpEDASJrKlt3ISMiQmyiJGQIMBLUckAEeVPAC8AtcEZUsqipFzj1gtzJgdAIFpHA0zIHAsUw8gAfiQrSvEbKnI8wKjPUwiOBjWaBmjqRILyrFZdhiY-hEiVyMGZdc9CGAmtwBAIiXGyqIUPovQ5o5eC-ZGH0ixw9U3X_YYgt6CgAYGjjTaDvAR-Mb_4DWuAjezR2TXPN8SUUhlqEIOo2voeSSpTU1V5CfKk11WK72pXC3saXWuPQxY6q2rSIb4aBcXEVuJT3hKgzOl1oZvGIK6oLGlTRS2hgzSDMR1aoNUPkQBdtZhupoGsffWtkqP5qP3RgDccRkFfBCaWFy9XTntrGyC2zsArhVJiXGz5feTktP2Hs0jrKHVYKybhZVX9e7anEX1RfhCTq0gSnEyOiH76fns_OBqI1OG1A2gtXQG4UTfoFx8YsZFk7qe_jYY-z50tJinRtVt4EcYXrsfImhq8D4R_uZemsgid8ybc_0ggRv2SYhJh4kUO4gedgCquZ13O0cqfLqkGIPAsJY3HYFOPf6b3WnjxxHQ-MMvusHbPxfmvXVH4054DV2bzxpv9prb90e9hbHSy82sweDnvrg-wZlM2FJdX5rDrvBr0P_UfLKvuoum9V95bKXqrsueququyL6r5X2XvV7ajux8GdF8PX71Rndav3VHXuqWx50F3qP1kb3F35tv4A6lV2Eyr7G93hyvXh_cX-17WtxxsHrZl6NF2drOT_d6nMQtLkVDzqN524nTQdL0lZCqEA99tU0JQ6SVO4TccVKfNbkEDJti1Tj7alDeED9VMZezxh7JA1NndprnXYGm8Jylt2zKjHWi5NbRk33ZilEMBQ7sROcsSSxniNy-YjPo0_HxZH_4P2mLV7e34et8bmr1xtnYAsZj45iYPsO294Elo
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%87%AA%E5%B7%B1%E5%85%8D%E7%96%AB%E6%80%A7%E8%82%9D%E7%96%BE%E6%82%A3%E6%82%A3%E8%80%85%E3%81%B8%E3%81%AE%E6%96%B0%E5%9E%8B%E3%82%B3%E3%83%AD%E3%83%8A%E3%82%A6%E3%82%A4%E3%83%AB%E3%82%B9%E3%83%AF%E3%82%AF%E3%83%81%E3%83%B3%E6%8E%A5%E7%A8%AE%E3%81%AB%E9%96%A2%E3%81%99%E3%82%8B%E6%83%85%E5%A0%B1%E6%8F%90%E4%BE%9B%E3%81%AB%E3%82%88%E3%82%8B%E5%BF%83%E7%90%86%E7%9A%84%E5%BD%B1%E9%9F%BF&rft.jtitle=%E8%82%9D%E8%87%93&rft.au=%E6%BB%9D%E5%B7%9D%2C+%E5%BA%B7%E8%A3%95&rft.au=%E6%9F%BF%E5%9D%82%2C+%E5%95%93%E4%BB%8B&rft.au=%E5%90%89%E7%94%B0%2C+%E9%9B%84%E4%B8%80&rft.au=%E9%88%B4%E6%9C%A8%2C+%E6%82%A0%E5%9C%B0&rft.date=2021-10-01&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA%E3%80%80%E6%97%A5%E6%9C%AC%E8%82%9D%E8%87%93%E5%AD%A6%E4%BC%9A&rft.issn=0451-4203&rft.eissn=1881-3593&rft.volume=62&rft.issue=10&rft.spage=613&rft.epage=619&rft_id=info:doi/10.2957%2Fkanzo.62.613&rft.externalDocID=article_kanzo_62_10_62_613_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0451-4203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0451-4203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0451-4203&client=summon